Stocktoria

Electromedical Technologies, Inc EMED

OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2019-06-17

Electromedical Technologies, Inc financials (annual, from 10-K)

Revenue
20192020202120222023
Net income
20192020202120222023
Free cash flow
20192020202120222023

Bars are annual figures from 2019 to 2023; red bars are negative (a loss or cash outflow).

MetricFY2023FY2022FY2021FY2020FY2019
Revenue$1.3M$1.1M$907,362$737,958$829,737
Gross profit$1.0M$888,641$708,128$543,574$591,221
R&D expense$231,434$92,299$215,320$31,600$82,849
SG&A expense$3.1M$2.5M$4.5M$3.7M$2.3M
Operating income-$2.1M-$1.6M-$3.8M-$3.2M-$1.7M
Interest expense$893,155$791,072$3.3M$769,591$54,814
Net income-$2.6M-$3.5M-$8.5M-$3.9M-$1.7M
EPS (diluted)$0.00$-0.03$-0.24$-0.20
Operating cash flow-$1.4M-$773,337-$1.2M-$1.3M-$280,772
Free cash flow-$1.6M
Cash & equivalents$87,704$368,425$383,170$264,913$0
Inventory$68,517$62,061$218,510$78,712$24,694
Total assets$748,383$1.4M$1.4M$1.4M$902,866
Total liabilities$3.6M$3.6M$2.1M$2.7M$3.1M
Shareholders' equity-$2.9M-$2.2M-$722,503-$1.3M-$2.2M

Growth · year-over-year · Revenue CAGR 12.9%

MetricFY2023FY2022FY2021FY2020FY2019
Revenue growth+17.3%+26.7%+23.0%-11.1%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0001715819 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.